Micro-organisms in your pills up next: scientist
Nascent discoveries give shot in the arm for biotech stocks
[SINGAPORE] The hottest thing in the already-hot biotechnology sector are tiny bugs, so investors should pay attention to the commercialisation of health supplements containing micro-organisms, an American biotech entrepreneur has said.
Stephen Turner, who founded Nasdaq-listed gene sequencing equipment maker Pacific Biosciences, said discoveries are coming thick and fast on the microbiome, that community of bacteria and other micro-organisms residing in the human gut, skin and eyes.
A microbiome supplement, for example, could be invented to aid oral health, working through the introduction of a specific form of bacteria to kick out other disease-causing bacteria.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
New Articles
Singapore top recipient of Q1 cross-border investments in Apac: Knight Frank
Dasin Retail Trust’s trustee-manager chairman, directors deny allegations of misconduct
Keppel Infrastructure Trust posts 29.1% lower Q1 distributable income
Bitcoin faces worst month since FTX crash with ETF demand cooling
AIA launches wealth centre targeting high-net-worth clients
Prudential’s Q1 new business profit down 2% at S$743 million